Clinical Trial
Non-invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated With Post-Traumatic Stress Disorder (PTSD)
ClinicalTrials.gov3/2/2026Β·03/02/26πΊπΈ USA
Summary
This open-label pilot tests whether electroCore's handheld gammaCore non-invasive vagus nerve stimulator is safe and helps as an added treatment for post-traumatic stress disorder in adults. It plans to enroll 40 participants in California and began in March 2026. The registry names Acacia Clinics as sponsor and electroCore and the Vagus Nerve Society as collaborators.
Why it matters
It tests an already marketed non-invasive device in a new psychiatric indication. As a single-group open-label pilot without a sham arm, it can suggest safety and feasibility but cannot show efficacy.
#Neurostimulation#VNS#Non-invasive#PTSD#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items β updated daily.
Start free trialAlready a member? Sign in